Sinonasal Therapies and Histologic Correlations of Patients With Cystic Fibrosis in the Era of Highly Effective Modulator Therapy

Recruiting

Phase 3

HEMTSinonasal Therapies and Histologic Correlations of Patients With Cystic Fibrosis in the Era of Highly Effective Modulator Therapy

Sponsor:

Indiana University

Code:

NCT06996951

Conditions

Cystic Fibrosis (CF)

Chronic Rhinosinusitis (CRS)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

:PULMONARY FUNCTION TEST

NASAL ENDOSCOPY

LEUKOSORB FILTER PAPER APPLICATION TO NASAL CAVITY

SINONASAL OUTCOME TEST 22 QUESTIONNAIRE

CYSTIC FIBROSIS QUESTIONNAIRE-REVISED

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-06. This information was provided to ClinicalTrials.gov by Indiana University on 2025-10-27.